跳至主要内容
临床试验/CTRI/2014/02/004435
CTRI/2014/02/004435已完成4 期

A PROSPECTIVE STUDY FOR THE COMPARATIVE EVALUATION OF SAFETY, EFFICACY AND COST EFFECTIVENESS OF VARIOUS ADD ON TREATMENT REGIMEN IN TYPE 2 DIABETES PATIENTS, NOT CONTROLLED BY METFORMIN ALONE

Vardhman Mahavir Medical college and Safdarjung Hospital0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • •type 2 diabetes mellitus either newly diagnosed or previously established with baseline HbA1c >=7%
  • •- not controlled by metformin alone needing additional antihyperglycaemic drugs
  • •- willing to provide written informed consent

排除标准

  • •- patients of type 1 diabetes,
  • •- patients on insulin treatment
  • •- secondary diabetes
  • •- complications on or during treatment plan
  • •- known or suspected hypersensitivity to study drugs
  • •- co-morbid illness like cardiovascular diseases, renal failure or liver diseases

研究者

发起方
Vardhman Mahavir Medical college and Safdarjung Hospital

相似试验